An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

March 29, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

February 28, 2027

Conditions
StargardtStargardt's DiseaseStargardt DiseaseSTGD1
Trial Locations (20)

10032

RECRUITING

Columbia University Medical Center, New York

RECRUITING

CUIMC/Edward S. Harkness Eye Institute, New York

21287

RECRUITING

Wilmer Eye Institute, Johns Hopkins University MD 21287, Baltimore

27710

RECRUITING

Duke Eye Center, Durham

30322

RECRUITING

Emory University, Atlanta

32607

RECRUITING

Vitreo Retinal Associates, Gainesville

33136

RECRUITING

Bascom Palmer Eye Institute, Miami

48105

RECRUITING

Kellogg Clinical Research Center, Ann Arbor

53127

RECRUITING

Universitätsklinikum Bonn, Klinik für Augenheilkunde, Bonn

53715

RECRUITING

University of Wisconsin, Madison, Madison

72076

RECRUITING

University Eye Hospital Tübingen, Tübingen

75231

RECRUITING

Retina Foundation of the Southwest, Dallas

80045

RECRUITING

UCHealth Sue Anschutz-Rodgers Eye Center, Aurora

92093

RECRUITING

Shiley Eye Institute, San Diego

97239

RECRUITING

Oregon Health & Science University, Portland

02114

RECRUITING

Massachusetts Eye and Ear Infirmary, Boston

EC1V 2PD

RECRUITING

Moorfields Eye Hospital, London

LS9 7T

RECRUITING

Leeds Teaching Hospitals NHS Trust, Leeds

M13 9WL

RECRUITING

University of Manchester - The Old St Mary's Hospital, Manchester

OX3 9DU

RECRUITING

Oxford Eye Hospital, Oxford

All Listed Sponsors
lead

Splice Bio

INDUSTRY